Back
EHRA Premium Access

Do we follow the recommendation of anticoagulation withdrawal after electrical cardioversion, in patients with atrial fibrillation?

Session: Poster session 3 - Atrial fibrillation - Clinical
Topic: Cardioversion and Defibrillation
Speaker: Doctor M. Vidal Burdeus (Barcelona, ES)
Event: EHRA 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Maria Vidal Burdeus

University Hospital Vall d'Hebron, Barcelona (Spain)
0 follower

39 more presentations in this session

Determinants of progression of persistent to permanent atrial fibrillation - data from the RACE 3 study

Speaker: Doctor R. De With (Groningen, NL)

Access
Abstract
Like
Thumbnail

The electrocardiographic and echocardiographic factors affecting infarct volume in acute ischaemic stroke

Speaker: Doctor D. Ranganathan (Montreal, CA)

Access
Abstract
Like
Thumbnail

Impact of incomplete revascularization in atrial fibrillation patients undergoing percutaneous coronary intervention: the afcas registry

Speaker: Associate Professor M. Proietti (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Cryptogenic stroke is associated with atrial fibrosis similar to atrial fibrillation

Speaker: Professor N. Akoum (Seattle, US)

Access
Abstract
Slides
Like
Thumbnail

Clinical factors related to successful or unsuccessful cardioversion in the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial

Speaker: Professor G. Lip (Liverpool, GB)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 3 - Atrial fibrillation - Clinical

Speakers: Doctor M. Vidal Burdeus, Doctor R. De With, Doctor D. Ranganathan, Associate Professor M. Proietti, Professor N. Akoum...
Access
Like
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources